FR2205510A1 - - Google Patents

Info

Publication number
FR2205510A1
FR2205510A1 FR7339046A FR7339046A FR2205510A1 FR 2205510 A1 FR2205510 A1 FR 2205510A1 FR 7339046 A FR7339046 A FR 7339046A FR 7339046 A FR7339046 A FR 7339046A FR 2205510 A1 FR2205510 A1 FR 2205510A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7339046A
Other languages
French (fr)
Other versions
FR2205510B3 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of FR2205510A1 publication Critical patent/FR2205510A1/fr
Application granted granted Critical
Publication of FR2205510B3 publication Critical patent/FR2205510B3/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
FR7339046A 1972-11-04 1973-11-02 Expired FR2205510B3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5095972A GB1401865A (en) 1972-11-04 1972-11-04 4-hexopyranosyl-2-deoxystreptamines

Publications (2)

Publication Number Publication Date
FR2205510A1 true FR2205510A1 (enExample) 1974-05-31
FR2205510B3 FR2205510B3 (enExample) 1976-09-17

Family

ID=10458102

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7339046A Expired FR2205510B3 (enExample) 1972-11-04 1973-11-02

Country Status (7)

Country Link
JP (1) JPS4986370A (enExample)
BE (1) BE806677A (enExample)
DE (1) DE2354122A1 (enExample)
FR (1) FR2205510B3 (enExample)
GB (1) GB1401865A (enExample)
LU (1) LU68736A1 (enExample)
NL (1) NL7314141A (enExample)

Also Published As

Publication number Publication date
JPS4986370A (enExample) 1974-08-19
LU68736A1 (enExample) 1975-06-24
BE806677A (fr) 1974-04-29
GB1401865A (en) 1975-08-06
DE2354122A1 (de) 1974-07-11
NL7314141A (enExample) 1974-05-07
FR2205510B3 (enExample) 1976-09-17

Similar Documents

Publication Publication Date Title
AU465352B2 (enExample)
AU480244B2 (enExample)
FR2205510B3 (enExample)
BG18646A1 (enExample)
BG18658A1 (enExample)
BG20063A1 (enExample)
CH1373772A4 (enExample)
CH524573A4 (enExample)
CH545566A (enExample)
CH561433A5 (enExample)
CH561741A5 (enExample)
CH561802A5 (enExample)
CH561852A5 (enExample)
CH561896A5 (enExample)
CH561936A5 (enExample)
CH562113A5 (enExample)
CH562995A5 (enExample)
CH564282A5 (enExample)
CH564354A5 (enExample)
CH564865A5 (enExample)
CH564971A5 (enExample)
CH564978A5 (enExample)
CH565246A5 (enExample)
CH565288A5 (enExample)
CH565411A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse